공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

신경자극 : 기술과 세계 시장

Neurostimulation: Technologies and Global Markets

리서치사 BCC Research
발행일 2021년 05월 상품 코드 1005705
페이지 정보 영문 121 Pages
가격
US $ 5,500 ₩ 6,527,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,833,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,400,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,280,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


신경자극 : 기술과 세계 시장 Neurostimulation: Technologies and Global Markets
발행일 : 2021년 05월 페이지 정보 : 영문 121 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 신경자극 기기 시장 규모는 2021년 71억 달러에서 2026년까지 98억 달러에 이를 전망입니다.

또한 예측기간중(2021-2026년간) 연평균 복합 성장률(CAGR)은 6.9%를 나타낼 것으로 예측됩니다.

세계의 신경자극(Neurostimulation) 기술/기기 시장을 분석했으며, 기술 개요와 활용 분야, 시장의 기본 구조, 주요 성장 촉진요인 및 억제요인, 전체적인 시장 규모 동향 전망(2020-2026년), 기술 유형별/제품별 상세 동향, 최근의 기술 개발 및 자본거래 동향, 주요 기업 개요와 사업 전개 상황 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약 및 하이라이트

제3장 시장 및 기술의 배경

  • 신경자극 : 개요
  • 신경자극 기술의 유형
  • 척추 자극
  • 뇌심부 자극 치료
  • 천골신경 자극(SNS)
  • 미주신경 자극 치료
  • 설하 신경자극
  • 경피적 전기 신경자극
  • 경두개 자기 자극(TMS)
  • 기타
  • 신경자극 기술/기기의 치료 응용
  • 만성 통증 관리
  • 신경질환
  • 요실금/변실금
  • 폐쇄성 수면무호흡
  • 만성 편두통/두통
  • 심혈관질환
  • 위장질환
  • 비만
  • 정신질환
  • 기술 개발
  • MRI의 호환성
  • 충전형/비충전형 기기

제4장 기술별/기기 유형별 시장 세분화

  • 세계의 신경자극 기기 시장 : 유형별
  • 척추 자극(SCS) 기기
  • 경피적 전기 신경자극(TENS) 기기
  • 뇌심부 자극 치료(DBS) 기기
  • 천골신경 자극(SNS) 기기
  • 미주신경 자극(VNS) 기기
  • 설하 신경자극(HGNS) 기기
  • 시장 규모와 예측
  • 경두개 자기 자극(TMS) 기기
  • 기타 유형의 신경자극 기기

제5장 지역별 시장 세분화

  • 세계의 신경자극 기기 시장 : 지역별
  • 북미
  • 유럽
  • 아시아
  • 기타 지역

제6장 용도별 시장 세분화

  • 세계의 신경자극 기기 시장 : 치료 용도별
  • 만성 통증
  • 요실금/변실금
  • 파킨슨병
  • 간질
  • 폐쇄성 수면무호흡(OSA)
  • 본태성 진전
  • 주요우울장애(MDD)/임상 우울증
  • 강박 장애(OCD)
  • 기타

제7장 주요 출시 제품 및 기술

  • 최근의 치료법 개선과 새로운 적응증
  • 척추 자극
  • 뇌심부 자극 치료
  • 천골신경 자극(SNS)
  • 미주신경 자극
  • 설하신경 자극
  • 경피적 전기 신경 자극
  • 경두개 자기 자극
  • 기타 유형의 자극법
  • 새로운 적응증과 신경자극 치료

제8장 경쟁 구도

  • 기업별 시장 점유율 : 제품 부문별
  • 척추 자극 기기
  • 뇌심부 자극 기기
  • 천골신경 자극 기기
  • 미주신경 자극 기기
  • 설하 신경 자극 기기
  • 경두개 자기 자극 기기
  • 경피적 전기 신경자극 기기
  • 업계의 최근 동향

제9장 시장 역학

  • 시장 동향
  • 성장 촉진요인
  • 성장 억제요인

제10장 코로나19(COVID-19)의 영향

제11장 기업 개요

  • ABBOTT LABORATORIES
  • ALEVA NEUROTHERAPEUTICS SA
  • AVERY BIOMEDICAL DEVICES INC.
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOINDUCTION LTD.
  • BIONESS INC.
  • BIOWAVE CORP.
  • BOSTON SCIENTIFIC CORP.
  • BRAINSWAY LTD.
  • COCHLEAR AMERICAS
  • CVRX INC.
  • ELECTROCORE INC.
  • INSPIRE MEDICAL SYSTEMS INC.
  • INTEGER HOLDINGS CORP.
  • LABORIE INC.
  • LIVANOVA PLC
  • MAG & MORE GMBH
  • MAGSTIM INC.
  • MEDTRONIC PLC
  • NALU MEDICAL INC.
  • NEUROMED CONSULTING INC.
  • NEUROMETRIX INC.
  • NEURONETICS INC.
  • NEUROPACE INC.
  • NEUROSIGMA INC.
  • NEUROVALENS LTD.
  • NEVRO CORP.
  • NEXSTIM PLC
  • NYXOAH SA
  • RESPICARDIA INC.
  • SOTERIX MEDICAL INC.
  • STIMWAVE LLC
  • SYNAPSE BIOMEDICAL INC.
  • TONICA ELEKTRONIK A/S
  • XAVANT TECHNOLOGY(PTY) LTD.

제12장 부록 : 두자어

LSH 21.06.16

List of Tables

  • Summary Table : Global Market for Neurostimulation Devices, by Type, Through 2026
  • Table 1 : Prevalence of Chronic Pain and High Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
  • Table 2 : U.S. Distribution Share of Location of Chronic Pin in the Body
  • Table 3 : Prevalence of Adult Overweight and Obese Population in Select Countries, 2014-2019
  • Table 4 : Global Market for Neurostimulation Devices, by Type, Through 2026
  • Table 5 : Global Market for Spinal Cord Stimulation (SCS) Devices, by Region, Through 2026
  • Table 6 : Global Market for Transcutaneous Electrical Nerve Stimulation (TENS) Devices, by Region, Through 2026
  • Table 7 : Global Market for Deep Brain Stimulation (DBS) Devices, by Region, Through 2026
  • Table 8 : Global Market for Sacral Nerve Stimulation (SNS) Devices, by Region, Through 2026
  • Table 9 : Global Market for Vagus Nerve Stimulation (VNS) Devices, by Region, Through 2026
  • Table 10 : Global Market for Hypoglossal Nerve Stimulation (HGNS) Devices, by Region, Through 2026
  • Table 11 : Global Market for Transcranial Magnetic Stimulation (TMS) Devices, by Region, Through 2026
  • Table 12 : Global Market for Other Types of Neurostimulation Devices, by Region, Through 2026
  • Table 13 : Global Market for Neurostimulation Devices, by Region, Through 2026
  • Table 14 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2026
  • Table 15 : Implantable Neurostimulation Devices Approved, January 2018-January 2021
  • Table 16 : Currently Available Spinal Cord Stimulation Systems
  • Table 17 : Currently Available Deep Brain Stimulation Systems
  • Table 18 : Currently Available Sacral Nerve Stimulation Systems
  • Table 19 : Currently Available Vagus Nerve Stimulation Systems
  • Table 20 : U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Pain Relief Treatment, January 2015-March 31, 2021
  • Table 21 : U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Treatment of Migraine Pain Relief, January 2015-March 31, 2021
  • Table 22 : Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
  • Table 23 : Currently Available Hypoglossal Nerve Stimulation Systems for Respiratory Insufficiency
  • Table 24 : Currently Available Peripheral Nerve Stimulation Systems
  • Table 25 : Currently Available Transcranial Magnetic Stimulating Systems
  • Table 26 : Currently Available Gastric Electrical Stimulation System
  • Table 27 : Neurostimulation Stimulation Product Pipeline Highlights
  • Table 28 : Active Clinical Trials on Spinal Cord Stimulation Technology
  • Table 29 : Active Clinical Trials on DBS Technology
  • Table 30 : Active Clinical Trials on VNS Technology
  • Table 31 : Active Clinical Trials on Sacral Nerve Stimulation Technology
  • Table 32 : Active Clinical Trials on Peripheral Nerve Stimulation Technology
  • Table 33 : Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
  • Table 34 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
  • Table 35 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
  • Table 36 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
  • Table 37 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
  • Table 38 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
  • Table 39 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020
  • Table 40 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market for Neurostimulation Devices, by Type, 2020-2026
  • Figure 1 : Global Market Shares of Neurostimulation Devices, by Type, 2020
  • Figure 2 : Global Market Shares of Spinal Cord Stimulation Devices, by Region, 2020
  • Figure 3 : Global Market Shares of Transcutaneous Electrical Nerve Stimulation Devices, by Region, 2020
  • Figure 4 : Global Market Shares of Deep Brain Stimulation Devices, by Region, 2020
  • Figure 5 : Global Market Shares of Sacral Nerve Stimulation Devices, by Region, 2020
  • Figure 6 : Global Market Shares of Vagus Nerve Stimulation Devices, by Region, 2020
  • Figure 7 : Global Market Shares of Hypoglossal Nerve Stimulation Devices, by Region, 2020
  • Figure 8 : Global Market Shares of Transcranial Magnetic Stimulation Devices, by Region, 2020
  • Figure 9 : Global Market Shares of Other Types of Neurostimulation Devices, by Region, 2020
  • Figure 10 : Global Market Shares of Other Neurostimulation Devices, by Region, 2020
  • Figure 11 : Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2020
  • Figure 12 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
  • Figure 13 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
  • Figure 14 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
  • Figure 15 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
  • Figure 16 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
  • Figure 17 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020

Highlights:

The global neurostimulation devices market should reach $9.8 billion by 2026 from $7.1 billion in 2021 at a compound annual growth rate (CAGR) of 6.9% for the forecast period of 2021 to 2026.

The spinal cord stimulation (SCS) devices segment of the global neurostimulation devices market is expected to grow from $2.3 billion in 2021 to $2.7 billion in 2026 at a CAGR of 3.4% for the forecast period of 2021 to 2026.

The deep brain stimulation (DBS) devices segment of the global neurostimulation devices market is expected to grow from $1.2 billion in 2021 to $2.1 billion in 2026 at a CAGR of 12.8% for the forecast period of 2021 to 2026.

Report Scope:

This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies/devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers a detailed study of therapeutic applications of neurostimulation technologies/devices including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies/devices includes historical data and market projection on sales by, device type, therapeutic applications and region.

For in-depth understanding of the market, profiles of market participants, key marketed devices, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global neurostimulation technology/devices market.

Report Includes:

  • 21 data tables and 20 additional tables
  • An overview of the global markets and technologies for neurostimulation
  • Estimation of the market size and analyses of market trends, with data from 2020, estimates for 2021 and projection of CAGR through 2026
  • Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
  • Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
  • Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
  • Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
  • Details about symptoms, progression and epidemiology of COVID-19 and discussion on impact of COVID-19 pandemic on medical industry as well as on neurostimulation market
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Abbott Laboratories, Boston Scientific, Medtronic PLC, NeuroMetrix, NeuroSigma and Soterix Medical Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Scope of This Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction to Neurostimulation
  • Types of Neurostimulation Technologies
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Others
  • Therapeutic Applications for Neurostimulation Technologies/Devices
  • Chronic Pain Management
  • Neurological Disorders
  • Urinary and Fecal Incontinence
  • Obstructive Sleep Apnea
  • Chronic Migraine and Headache
  • Cardiovascular Diseases
  • Gastrointestinal Disorders
  • Obesity
  • Psychiatric Disorders
  • Technology Developments
  • MRI Compatibility
  • Rechargeable and Non-rechargeable Devices

Chapter 4 Market Breakdown by Technology/Device Type

  • Global Market for Neurostimulation Devices by Type
  • Spinal Cord Stimulation (SCS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Deep Brain Stimulation (DBS) Devices
  • Sacral Nerve Stimulation (SNS) Devices
  • Vagus Nerve Stimulation (VNS) Devices
  • Hypoglossal Nerve Stimulation (HGNS) Devices
  • Market Size and Forecast
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Other Types of Neurostimulation Devices

Chapter 5 Market Breakdown by Region

  • Global Markets for Neurostimulation Devices by Region
  • North America
  • Europe
  • Asia
  • RoW

Chapter 6 Market Breakdown by Application

  • Global Market for Neurostimulation Devices by Therapeutic Application
  • Chronic Pain
  • Urinary and Fecal Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Obstructive Sleep Apnea (OSA)
  • Essential Tremor
  • Major Depressive Disorder (MDD)/Clinical Depression
  • Obsessive Compulsive Disorder (OCD)
  • Others

Chapter 7 Key Marketed Products and Technologies

  • Recent Therapeutic Improvements and New Indications
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Other Types of Stimulation
  • New Indications and Neurostimulation Therapies

Chapter 8 Competitive Landscape

  • Company Market Shares by Product Segment
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Hypoglossal Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Recent Industry Activities

Chapter 9 Market Dynamics

  • Market Trends
  • Growth Drivers
  • Market Restraints

Chapter 10 Impact of COVID-19

Chapter 11 Company Profiles

  • ABBOTT LABORATORIES
  • ALEVA NEUROTHERAPEUTICS SA
  • AVERY BIOMEDICAL DEVICES INC.
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOINDUCTION LTD.
  • BIONESS INC.
  • BIOWAVE CORP.
  • BOSTON SCIENTIFIC CORP.
  • BRAINSWAY LTD.
  • COCHLEAR AMERICAS
  • CVRX INC.
  • ELECTROCORE INC.
  • INSPIRE MEDICAL SYSTEMS INC.
  • INTEGER HOLDINGS CORP.
  • LABORIE INC.
  • LIVANOVA PLC
  • MAG & MORE GMBH
  • MAGSTIM INC.
  • MEDTRONIC PLC
  • NALU MEDICAL INC.
  • NEUROMED CONSULTING INC.
  • NEUROMETRIX INC.
  • NEURONETICS INC.
  • NEUROPACE INC.
  • NEUROSIGMA INC.
  • NEUROVALENS LTD.
  • NEVRO CORP.
  • NEXSTIM PLC
  • NYXOAH SA
  • RESPICARDIA INC.
  • SOTERIX MEDICAL INC.
  • STIMWAVE LLC
  • SYNAPSE BIOMEDICAL INC.
  • TONICA ELEKTRONIK A/S
  • XAVANT TECHNOLOGY (PTY) LTD.

Chapter 12 Appendix: Acronyms

Back to Top
전화 문의
F A Q